475 related articles for article (PubMed ID: 1832462)
1. Up-regulation of renal adenylate cyclase-coupled vasopressin receptors after chronic administration of vasopressin antagonists to rats.
Caltabiano S; Kinter LB
J Pharmacol Exp Ther; 1991 Sep; 258(3):1046-54. PubMed ID: 1832462
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic action of neurohypophysial peptides: effects of agonists and antagonists and implication of natriuretic receptor.
Chan WY; Hruby VJ
J Pharmacol Exp Ther; 1988 Aug; 246(2):597-602. PubMed ID: 2969979
[TBL] [Abstract][Full Text] [Related]
3. Biologic response to chronic blockade of vasopressin receptors in Sprague-Dawley rats.
Mah SC; Opperman JR; Baum HP; Hofbauer KG
J Pharmacol Exp Ther; 1988 Jun; 245(3):1021-7. PubMed ID: 2968447
[TBL] [Abstract][Full Text] [Related]
4. Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.
Serradeil-Le Gal C; Lacour C; Valette G; Garcia G; Foulon L; Galindo G; Bankir L; Pouzet B; Guillon G; Barberis C; Chicot D; Jard S; Vilain P; Garcia C; Marty E; Raufaste D; Brossard G; Nisato D; Maffrand JP; Le Fur G
J Clin Invest; 1996 Dec; 98(12):2729-38. PubMed ID: 8981918
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.
Jard S; Gaillard RC; Guillon G; Marie J; Schoenenberg P; Muller AF; Manning M; Sawyer WH
Mol Pharmacol; 1986 Aug; 30(2):171-7. PubMed ID: 3016500
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of novel antidiuretic antagonists: analysis of the effects on vasopressin binding and adenylate cyclase activation in animal and human kidney.
Stassen FL; Erickson RW; Huffman WF; Stefankiewicz J; Sulat L; Wiebelhaus VD
J Pharmacol Exp Ther; 1982 Oct; 223(1):50-4. PubMed ID: 7120127
[TBL] [Abstract][Full Text] [Related]
7. Response of toad urinary bladder to vasopressin analogs possessing V1 or V2 specificity.
Higgins JT; Gupta SK
Prog Clin Biol Res; 1988; 258():93-101. PubMed ID: 2967974
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
Walker LA; Frölich JC
J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
[TBL] [Abstract][Full Text] [Related]
10. Vascular vasopressin receptors mediate inhibition of beta adrenergic receptor-induced cyclic AMP accumulation.
Nambi P; Whitman M; Stassen FL; Crooke ST
J Pharmacol Exp Ther; 1986 Apr; 237(1):143-6. PubMed ID: 3007735
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the pharmacologic properties of a vasopressin antagonist in Brattleboro rats.
Mah SC; Hofbauer KG
J Pharmacol Exp Ther; 1988 Jun; 245(3):1028-32. PubMed ID: 2968448
[TBL] [Abstract][Full Text] [Related]
12. Iodination of vasopressin analogues with agonistic and antagonistic properties: effects on biological properties and affinity for vascular and renal vasopressin receptors.
Jard S; Lombard C; Seyer R; Aumelas A; Manning M; Sawyer WH
Mol Pharmacol; 1987 Sep; 32(3):369-75. PubMed ID: 2959851
[TBL] [Abstract][Full Text] [Related]
13. Antidiuretic effects of a nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to rats.
Nakamura S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Yamamura Y; Mori T; Tominaga M
J Pharmacol Exp Ther; 2000 Dec; 295(3):1005-11. PubMed ID: 11082435
[TBL] [Abstract][Full Text] [Related]
14. Interaction between arginine vasopressin and angiotensin II receptors in the central regulation of sodium balance.
Saad WA; Camargo LA; Antunes-Rodrigues J; Saad WA; Guarda IF; Guarda RS
Regul Pept; 2005 Dec; 132(1-3):53-8. PubMed ID: 16198010
[TBL] [Abstract][Full Text] [Related]
15. Effects of thyroid deficiency on the vasopressin receptors in the kidney of developing and adult rats. A comparative study of hormonal binding and adenylate cyclase activation.
Ali M; Guillon G; Balestre MN; Clos J
Horm Metab Res; 1987 Mar; 19(3):115-21. PubMed ID: 2952571
[TBL] [Abstract][Full Text] [Related]
16. Antidiuretic hormone antagonists and aquaresis in dogs: different vasopressin sensitivity and antagonist potency in renal cortex and papilla.
Stassen FL; Heckman GD; Huffman WF; Kinter LB
J Pharmacol Exp Ther; 1985 Jan; 232(1):100-5. PubMed ID: 3965688
[TBL] [Abstract][Full Text] [Related]
17. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
18. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs.
Liard JF
J Cardiovasc Pharmacol; 1988 Feb; 11(2):174-80. PubMed ID: 2452311
[TBL] [Abstract][Full Text] [Related]
19. Cellular action of antidiuretic hormone in mice with inherited vasopressin-resistant urinary concentrating defects.
Dousa TP; Valtin H
J Clin Invest; 1974 Sep; 54(3):753-62. PubMed ID: 4368480
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of antidiuretic hormone on urinary prostaglandin excretion.
Fejes-Toth G; Naray-Fejes-Toth A; Frölich JC
J Pharmacol Exp Ther; 1983 Oct; 227(1):215-9. PubMed ID: 6578322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
